Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Resource and Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
Faulty oxygen sensing disrupts angiomotin function in trophoblast cell migration and predisposes to preeclampsia
Abby Farrell, … , Martin Post, Isabella Caniggia
Abby Farrell, … , Martin Post, Isabella Caniggia
Published April 18, 2019
Citation Information: JCI Insight. 2019;4(8):e127009. https://doi.org/10.1172/jci.insight.127009.
View: Text | PDF
Research Article Cell biology Reproductive biology

Faulty oxygen sensing disrupts angiomotin function in trophoblast cell migration and predisposes to preeclampsia

  • Text
  • PDF
Abstract

Human placenta development and a successful pregnancy is incumbent upon precise oxygen-dependent control of trophoblast migration/invasion. Persistent low oxygen leading to failed trophoblast invasion promotes inadequate spiral artery remodeling, a characteristic of preeclampsia. Angiomotin (AMOT) is a multifaceted scaffolding protein involved in cell polarity and migration, yet its upstream regulation and significance in the human placenta remain unknown. Herein, we show that AMOT is primarily expressed in migratory extravillous trophoblast cells (EVTs) of the intermediate and distal anchoring column. Its expression increases after 10 weeks of gestation when oxygen tension rises and EVT migration/invasion peaks. Time-lapse imaging confirmed that the AMOT 80-kDa isoform promotes migration of trophoblastic JEG3 and HTR-8/SVneo cells. In preeclampsia, however, AMOT expression is decreased and its localization to migratory fetomaternal interface EVTs is disrupted. We demonstrate that Jumonji C domain–containing protein 6 (JMJD6), an oxygen sensor, positively regulates AMOT via oxygen-dependent lysyl hydroxylation. Furthermore, in vitro and ex vivo studies show that transforming growth factor-β (TGF-β) regulates AMOT expression, its interaction with polarity protein PAR6, and its subcellular redistribution from tight junctions to cytoskeleton. Our data reveal an oxygen- and TGF-β–driven migratory function for AMOT in the human placenta, and implicate its deficiency in impaired trophoblast migration that plagues preeclampsia.

Authors

Abby Farrell, Sruthi Alahari, Leonardo Ermini, Andrea Tagliaferro, Michael Litvack, Martin Post, Isabella Caniggia

×

Figure 7

JMJD6 regulates AMOT subcellular localization and its lysyl hydroxylation in migratory HTR-8/SVneo cells.

Options: View larger image (or click on image) Download as PowerPoint
JMJD6 regulates AMOT subcellular localization and its lysyl hydroxylatio...
(A) Representative immunofluorescence (IF) images of AMOT (green) and JMJD6 (red) in HTR-8/SVneo cells following silencing of JMJD6 (n = 3 independent experiments). (B) Representative IF images of (i) AMOT and JMJD6, and (ii) AMOT and phalloidin in HTR-8/SVneo cells following overexpression of JMJD6 and JMJD6 with mutated catalytic JMJC domain (n = 4). (C) Linear migration rate for HTR-8/SVneo cells overexpressing JMJD6 expressed as fold change relative to empty vector (EV) control (n = 4). (D) Representative IF images of AMOT in HTR-8/SVneo cells following treatment with 20 μM minoxidil for 48 hours (n = 4). (E) Linear migration rate for HTR-8/SVneo cells treated with 20 μM minoxidil for 48 hours expressed as fold change relative to vehicle control (n = 4). *P < 0.05 by nonparametric Mann-Whitney U test. Original magnification, ×40 (all images).

Copyright © 2022 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts